OCT 16, 2026 · JOURNAL ARTICLE
A High-Throughput Screening Platform for the Discovery of Noncovalent Inhibitors of the ISG15–UBA7 Interaction
Acs Medicinal Chemistry Letters
Abstract Patients with metastatic breast cancer have a dismal five-year survival rate of 28% because these cancers develop resistance to multiple treatment modalities; thus, novel